SCHEMBL1824554

SCHEMBL1824554

CCOC(=O)CC(c1cccc(OS(C)(=O)=O)c1)C(N)Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
F10 P00742 2/20 0.42
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PPARG P37231 3/20 0.38
BCHE P06276 4/20 0.38
ACHE P22303 4/20 0.38
MTNR1A P48039 2/20 0.38
MTNR1B P49286 2/20 0.38
PPARA Q07869 2/20 0.37
F2 P00734 2/20 0.37
FAAH O00519 1/20 0.37
SLC15A1 P46059 1/20 0.36
CYP2D6 P10635 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1827195 0.92 SLC15A1 (0.46) KMT2ASMN1; SMN2PPARGBCHEACHE
SCHEMBL1823449 0.90 F10 (0.41) F10KMT2ASMN1; SMN2BCHEACHE
SCHEMBL1827164 0.90 MTNR1A (0.43) KMT2ASMN1; SMN2BCHEACHEMTNR1A
SCHEMBL1826619 0.89 PPARG (0.44) F10PPARGPPARAF2SLC15A1
SCHEMBL1823346 0.88 BCHE (0.40) F10KMT2ASMN1; SMN2BCHEACHE
SCHEMBL1825023 0.88 P2RX7 (0.40) F10KMT2ASMN1; SMN2
SCHEMBL1823860 0.87 CA2 (0.41) KMT2ASMN1; SMN2BCHEACHEMTNR1A
SCHEMBL3578426 0.86 KMT2A (0.43) F10KMT2ASMN1; SMN2PPARGPPARA
SCHEMBL1824851 0.85 PPARG (0.41) KMT2ASMN1; SMN2PPARGBCHEACHE
SCHEMBL1826709 0.81 P2RX7 (0.44) KMT2ASMN1; SMN2SLC15A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 F10 1460/4885KMT2A 1068/4885SMN1; SMN2 2274/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 F10 1977/4885KMT2A 1084/4885SMN1; SMN2 3216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.